Clinical trial
A Review of Meta-Analyses on Bioavailable Stannous Fluoride Dentifrices: Effects on Dental Plaque
Name
2019SnF2PlaqueAnalysis
Description
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.
Trial arms
Trial start
2018-01-08
Estimated PCD
2018-11-30
Trial end
2018-11-30
Status
Completed
Treatment
Stannous fluoride dentifrice
Stannous fluoride (0.454%) dentifrice
Arms:
Stannous Fluoride Dentifrice
Positive control dentifrice
Positive control dentifrice containing (0.3%) triclosan.
Arms:
Positive control dentifrice
Negative control dentifrice
Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)
Arms:
Negative control dentifrice
Size
2359
Primary endpoint
Dental Plaque Scores
Up to 12 weeks
Eligibility criteria
Subjects were excluded from this study for the following reasons;
* pregnancy,
* rampant caries,
* severe periodontitis,
* at discretionary of the Principal Investigator.
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'OTHER', 'timePerspective': 'RETROSPECTIVE'}, 'enrollmentInfo': {'count': 2359, 'type': 'ACTUAL'}}
Updated at
2023-11-18
1 organization
3 products
1 indication
Organization
Procter and GambleProduct
Stannous fluorideIndication
Dental PlaqueProduct
Positive control dentifriceProduct
Negative control dentifrice